- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03874962
Improvements in Pneumonia Status After Oral Care Intervention in Taiwan
March 12, 2019 updated by: Kaohsiung Medical University Chung-Ho Memorial Hospital
Improvements in Pneumonia Status and Salivary Bacterial Concentration After Professional Oral Care Intervention in Taiwanese Nursing Home Residents
The correlation between improvement in oral health, reduction in oral bacterial concentration, and status of pneumonia hospitalization remains unclear.
To determine the effects of professional oral care intervention on the index of oral health, salivary and sputum bacterial concentrations, and pneumonia hospitalization status of nursing home residents using a quasi-experimental study.
Two nursing homes were on demand selected as the intervention and control groups; in the intervention group, weekly professional oral care was administered in addition to regular oral care by trained dental hygienists.
Demographic data and oral health status were analyzed.
Total salivary and sputum bacterial concentrations were determined using real-time polymerase chain reaction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
220
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
51 years to 102 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Informed consent
- 51 year-old and above
- Being bedridden for ≥ 6 months
- Positive sputum production
- Difficulty in swallowing reported by caregivers
Exclusion Criteria:
- Below 51 year-old
- Patients or family refused any oral care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Routine oral cleaning and professional oral care group
The subjects in "Routine oral cleaning and professional oral care group" were received about routine oral cleaning and professional oral care.
|
Besides routine oral cleaning was conducted by caregivers, professional oral care intervention was conducted by dental hygienists, and it included muscle massage, oral cleaning, and oral health education once a week.
|
|
No Intervention: Routine oral cleaning group
The subjects in "Routine oral cleaning group" were received only routine oral cleaning, just maintain daily condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pneumonia hospitalization status
Time Frame: 2 hours
|
Hospitalization prevalence and days of each hospitalization due to pneumonia were collected from medical records by questionnaire.
|
2 hours
|
|
Bacterial concentrations
Time Frame: 3 hours
|
Total salivary and sputum bacterial concentrations were determined using real-time polymerase chain reaction.
Staphylococcus aureus (strain ID: ATCC 29213) was used to create the standard growth curve of bacteria.
After overnight culture, the samples were prepared by 5-fold serial dilution with normal saline and plating in a Petri dish to produce 2.5×103 to 3.9×107 CFU/mL of bacteria.
Genomic DNA of bacteria was extracted from 1 mL of each bacterial serial solution using the modified standard method, which followed three basic steps: lysis, precipitation, and purification.
The DNA extracts were resuspended in 20 µL of distilled water and stored at -80°C until real-time polymerase chain reaction (RT-PCR) amplification.
The standard curve of bacterial concentration was generated by the bacterial 16S rRNA gene using a serial dilution of Staphylococcus aureus genomic DNA and StepOnePlus Real-Time PCR System (Applied Biosystems).
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral health examinations
Time Frame: 3 hours
|
Oral health examinations were conducted by two trained dentists, and data on plaque, gingival, and tongue coating indexes were collected by oral examination tables.
|
3 hours
|
|
Demographic data
Time Frame: 1 hour
|
Demographic data included gender, age groups, conscious, educational level, and nutritional route, which were collected by questionnaire.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Shun-Te Huang, Professor, Kaohsiung Medical University Chung-Ho Memorial Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cao Y, Liu C, Lin J, Ng L, Needleman I, Walsh T, Li C. Oral care measures for preventing nursing home-acquired pneumonia. Cochrane Database Syst Rev. 2022 Nov 16;11(11):CD012416. doi: 10.1002/14651858.CD012416.pub3.
- Chiang TC, Huang MS, Lu PL, Huang ST, Lin YC. The effect of oral care intervention on pneumonia hospitalization, Staphylococcus aureus distribution, and salivary bacterial concentration in Taiwan nursing home residents: a pilot study. BMC Infect Dis. 2020 May 27;20(1):374. doi: 10.1186/s12879-020-05061-z.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2015
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
September 30, 2017
Study Registration Dates
First Submitted
April 18, 2018
First Submitted That Met QC Criteria
March 12, 2019
First Posted (Actual)
March 14, 2019
Study Record Updates
Last Update Posted (Actual)
March 14, 2019
Last Update Submitted That Met QC Criteria
March 12, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KMUH103-3M47
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified IPD for outcome measures will be made available.
IPD Sharing Time Frame
starting 6 months after publication
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial PneumoniaChina
Clinical Trials on Routine oral cleaning and professional oral care group
-
Children's Hospital of Fudan UniversityCompletedPremature InfantsChina
-
University Hospital, BordeauxTeleflexCompletedAspiration | Ventilator Acquired PneumoniaFrance
-
Henan Cancer HospitalNot yet recruitingAdvanced or Metastatic Breast CancerChina
-
Balikesir UniversityCompletedPatient Care in Intensive Care UnitsTurkey (Türkiye)
-
Şule GüzleNot yet recruitingAnorexia | Hematologic Neoplasms | Nausea | Vomiting
-
Karabuk UniversityCompleted
-
Oelisoa AndriankajaNot yet recruitingObesity | Dental Care for ChildrenUnited States
-
National Cheng-Kung University HospitalCompletedPneumonia, Bacterial | Oral HygieneTaiwan
-
Cairo UniversityNot yet recruitingB Thalassemia Major
-
Baqiyatallah Medical Sciences UniversityShahid Beheshti University; Tehran University of Medical SciencesCompletedVentilator-associated Pneumonia